Skip to main content
. 2021 Nov 2;11:21423. doi: 10.1038/s41598-021-00897-0

Table 3.

Comparison of patients who were and were not splenic infarction cases. The two groups were matched by age, gender, and ED triage levels.

Splenic infarct (n = 128) Non-splenic infarct (n = 377) p value
Age 61.9 (15.9) 61.7 (15.9) 0.170
Male 74 (57.8) 216 (57.3) 0.918
Triage level 0.956
Level I 3 (2.34) 6 (1.59)
Level II 39 (30.5) 116 (30.7)
Level III 81 (63.3) 241 (63.9)
Level IV 5 (3.91) 14 (3.71)
Initial vital signs
Fever (BT > 38 °C) 13 (10.2) 10 (2.65) 0.006
Tachycardia (HR > 100) 44 (34.4) 64 (17.0) < 0.001
Tachypnea (RR > 20) 14 (10.9) 25 (6.63) 0.106
Hypotension (SBP < 90) 3 (2.34) 8 (2.13) 0.491
Desaturation (SpO2 < 90%) 1 (1.59) 2 (1.79) 0.766
Conscious change (GCS < 14) 4 (3.31) 6 (1.59) 0.361
qSOFA ≥ 1 28 (21.9) 46 (12.2) 0.011
Previous medical history
Hypertension 59 (46.1) 38 (10.1) < 0.001
Diabetes mellitus 30 (23.4) 160 (42.4) < 0.001
Chronic liver disease 13 (10.2) 175 (46.4) < 0.001
COPD 2 (1.56) 130 (34.5) < 0.001
Chronic kidney disease 15 (11.7) 124 (32.9) < 0.001
Malignancy 12 (9.38) 109 (28.9) < 0.001
Atrial fibrillation 30 (23.4) 31 (8.22) < 0.001
Congestive heart failure 15 (11.7) 96 (25.5) < 0.001
Laboratory abnormality
Leukocytosis (WBC > 10,000) 76 (65.0) 114 (30.2) < 0.001
Thrombocytopenia (platelet < 100 K) 28 (23.9) 26 (6.97) < 0.001
CRP elevation (> 100) 19 (23.5) 17 (8.50) 0.001
BUN elevation (> 30) 6 (8.11) 28 (18.4) 0.104
ALT elevation (> 120) 2 (2.20) 10 (4.17) 0.672
Prognosis
Length of stay 14.3 (12.7) 3.2 (8.48) < 0.001
ICU admission 18 (14.1) 6 (1.59) < 0.001
Mortality 8 (6.25) 0 (0) < 0.001